Advertisement

Heart failure and anemia: Effects on prognostic variables

Published:September 28, 2016DOI:https://doi.org/10.1016/j.ejim.2016.09.011

      Highlights

      • Anemia is frequent in HF patients.
      • Little is known on how to manage HF prognostic parameters in anemic HF patients.
      • Cardiopulmonary exercise evaluation can be safely performed in anemic HF patients.
      • Cardiopulmonary exercise provides prognostic information in anemic HF patients.
      • However VE/VCO2 slope loses its prognostic power in patients with Hb < 11.0 g/dL.

      Abstract

      Background

      Anemia is frequent in heart failure (HF), and it is associated with higher mortality. The predictive power of established HF prognostic parameters in anemic HF patients is unknown.

      Methods

      Clinical, laboratory, echocardiographic and cardiopulmonary-exercise-test (CPET) data were analyzed in 3913 HF patients grouped according to hemoglobin (Hb) values. 248 (6%), 857 (22%), 2160 (55%) and 648 (17%) patients had very low (<11 g/dL), low (11–12 for females, 11–13 for males), normal (12–15 for females, 13–15 for males) and high (>15) Hb, respectively.

      Results

      Median follow-up was 1363 days (606–1883). CPETs were always performed safely. Hb was related to prognosis (Hazard ratio (HR) = 0.864). No prognostic difference was observed between normal and high Hb groups. Peak oxygen consumption (VO2), ventilatory efficiency (VE/VCO2 slope), plasma sodium concentration, ejection fraction (LVEF), kidney function and Hb were independently related to prognosis in the entire population. Considering Hb groups separately, peakVO2 (very low Hb HR = 0.549, low Hb HR = 0.613, normal Hb HR = 0.618, high Hb HR = 0.542) and LVEF (very low Hb HR = 0.49, low Hb HR = 0.692, normal Hb HR = 0.697, high Hb HR = 0.694) maintained their prognostic roles. High VE/VCO2 slope was associated with poor prognosis only in patients with low and normal Hb.

      Conclusions

      Anemic HF patients have a worse prognosis, but CPET can be safely performed. PeakVO2 and LVEF, but not VE/VCO2 slope, maintain their prognostic power also in HF patients with Hb < 11 g/dL, suggesting CPET use and a multiparametric approach in HF patients with low Hb. However, the prognostic effect of an anemia-oriented follow-up is unknown.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Triposkiadis F.
        • Giamouzis G.
        • Parissis J.
        • et al.
        Reframing the association and significance of co-morbidities in heart failure.
        Eur J Heart Fail. 2016; 18: 744-758
        • Berry C.
        • Poppe K.K.
        • Gamble G.D.
        • et al.
        Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.
        QJM. 2015; (Epub ahead of print)https://doi.org/10.1093/qjmed/hcv087
        • He S.W.
        • Wang L.X.
        The impact of anemia on the prognosis of chronic heart failure: a meta-analysis and systemic review.
        Congest Heart Fail. 2009; 15: 123-130
        • Kaiafa G.
        • Kanellos I.
        • Savopoulos C.
        • et al.
        Is anemia a new cardiovascular risk factor?.
        Int J Cardiol. 2015; 186: 117-124
        • McCullough P.A.
        • Barnard D.
        • Clare R.
        • et al.
        Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
        Clin Cardiol. 2013; 36: 611-620
        • Yamauchi T.
        • Sakata Y.
        • Takada T.
        • et al.
        Prognostic impact of anemia in patients with chronic heart failure—with special reference to clinical background: report from the CHART-2 study.
        Circ J. 2015; 79: 1984-1993
        • Mentz R.J.
        • Kelly J.P.
        • von Lueder T.G.
        • et al.
        Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.
        J Am Coll Cardiol. 2014; 64: 2281-2293
        • Agostoni P.
        • Corra U.
        • Cattadori G.
        • et al.
        Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis.
        Int J Cardiol. 2013; 167: 2710-2718
        • Levy W.C.
        • Mozaffarian D.
        • Linker D.T.
        • et al.
        The Seattle Heart Failure Model: prediction of survival in heart failure.
        Circulation. 2006; 113: 1424-1433
        • Corra U.
        • Piepoli M.F.
        • Carre F.
        • et al.
        Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the cardiac rehabilitation section of the European Association of Cardiovascular Prevention and Rehabilitation.
        Eur Heart J. 2010; 31: 1967-1974
        • Hillege H.L.
        • Nitsch D.
        • Pfeffer M.A.
        • et al.
        Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
        Circulation. 2006; 113: 671-678
        • Lang R.M.
        • Bierig M.
        • Devereux R.B.
        • et al.
        Recommendations for chamber quantification.
        Eur J Echocardiogr. 2006; 7: 79-108
        • Wasserman K.
        • Hansen J.E.
        • Sue D.Y.
        • Stringer W.W.
        • Whipp B.J.
        Clinical exercise testing. Principles of exercise testing and interpretation including pathophysiology and clinical applications.
        Lippincott Williams & Wilkins, 2005: 138-139
        • Agostoni P.
        • Bianchi M.
        • Moraschi A.
        • et al.
        Work-rate affects cardiopulmonary exercise test results in heart failure.
        Eur J Heart Fail. 2005; 7: 498-504
        • Corra U.
        • Pistono M.
        • Mezzani A.
        • et al.
        Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence.
        Circulation. 2006; 113: 44-50
        • McLean E.
        • Cogswell M.
        • Egli I.
        • et al.
        Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005.
        Public Health Nutr. 2009; 12: 444-454
        • Kleber F.X.
        • Vietzke G.
        • Wernecke K.D.
        • et al.
        Impairment of ventilatory efficiency in heart failure: prognostic impact.
        Circulation. 2000; 101: 2803-2809
        • Arena R.
        • Myers J.
        • Abella J.
        • et al.
        Development of a ventilatory classification system in patients with heart failure.
        Circulation. 2007; 115: 2410-2417
        • Chang A.J.
        • Ortega F.E.
        • Riegler J.
        • et al.
        Oxygen regulation of breathing through an olfactory receptor activated by lactate.
        Nature. 2015; 527: 240-244